ADVERTISEMENT

Onderstepoort Biological Products (OBP)

Financial Information

All Financial Values: R'0002023/242022/232021/222020/212019/20
 
AUDIT OUTCOME QualifiedQualifiedFinancially UnqualifiedFinancially UnqualifiedFinancially Unqualified
 
FINANCIAL POSITION
Current Assets553 775478 241426 615425 479430 791
Non-Current Assets385 597388 615343 344351 727343 489
Total Assets939 372866 856769 959777 206774 281
Current Liabilities119 67591 69334 25834 50523 071
Non-Current Liabilities453 145454 565456 420468 777478 739
Total Liabilities572 820546 259490 678503 282501 810
Total Net Assets366 552320 596279 281273 924272 471
 
FINANCIAL PERFORMANCE
Total Revenue291 514258 836208 667253 692220 575
Revenue from Exchange Transactionsn/an/an/an/an/a
Revenue from Non-Exchange Transactionsn/an/an/an/an/a
Total Expenditure(248 772)(227 167)(203 310)(252 239)(221 759)
Employee Related costs(90 818)(87 191)(92 501)(92 426)(88 409)
Surplus/(Deficit) for Year42 74231 6695 3571 453(1 184)
 
CASH FLOW
Net Cash Flows from Operating Activities98 652109 13141 0196 693(11 462)
Net Cash Flows from Investing Activities(13 486)(44 393)(6 358)(18 469)(94 286)
Cash & Cash Equivalents at End of Year458 531373 371308 778274 289286 239
 
UIFW EXPENDITURE
Unauthorised Expenditure-----
Irregular Expenditure3 152 694-4249 4001 999
Fruitless & Wasteful Expenditure-8-4 9487 425
 
HUMAN RESOURCES
Posts Approved265278278277274
Posts Filled174196196205209
 
SOURCEAnnual ReportAnnual ReportAnnual ReportAnnual ReportAnnual Report

The information in this directory is compiled from various sources and is subject to continual change. If you notice any errors or omissions, contact us so that we may correct them.

ADVERTISEMENT
ADVERTISEMENT